Bangkok Lab and Cosmetics

Bangkok Lab and Cosmetics (BLC) is a leading Thai pharmaceutical company specializing in the research, development, and manufacture of generic drugs, herbal medicines, and cosmetic products. Established in 1992, the company operates a comprehensive manufacturing facility in Ratchaburi that adheres to international GMP and PIC/S standards. BLC's product portfolio includes a wide range of therapeutic categories such as antibiotics, analgesics, and gastrointestinal treatments, as well as specialized animal health products. The company is a significant player in the Southeast Asian healthcare market, focusing on providing high-quality and affordable medical solutions. Following its successful listing on the Stock Exchange of Thailand in 2023, BLC has focused on expanding its "New Generic" pipeline and enhancing its R&D capabilities. Their business model integrates manufacturing, distribution, and marketing to serve both domestic and international healthcare providers.